SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001645842-21-000031
Filing Date
2021-11-03
Accepted
2021-11-03 16:08:48
Documents
13
Period of Report
2021-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zy-20211103.htm   iXBRL 8-K 34050
2 EX-99.1 exhibit9912021q3.htm EX-99.1 85979
  Complete submission text file 0001645842-21-000031.txt   272761

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zy-20211103.xsd EX-101.SCH 1896
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zy-20211103_lab.xml EX-101.LAB 25848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zy-20211103_pre.xml EX-101.PRE 13579
6 EXTRACTED XBRL INSTANCE DOCUMENT zy-20211103_htm.xml XML 11377
Mailing Address 6121 HOLLIS STREET, SUITE 700 EMERYVILLE CA 94608
Business Address 6121 HOLLIS STREET, SUITE 700 EMERYVILLE CA 94608 (415) 801-8073
Zymergen Inc. (Filer) CIK: 0001645842 (see all company filings)

IRS No.: 462942439 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40354 | Film No.: 211375399
SIC: 8731 Services-Commercial Physical & Biological Research